|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BAC Encompasses Regulatory Sequences for Expression in Vascular and Visceral Smooth Muscles at Fetal and Adult Stages
1 Department of Internal Medicine, Wayne State University, Detroit, MI, USA
2 Environmental Health Sciences Center, Wayne State University, Detroit, MI, USA
3 Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA
4 Department of Internal Medicine, Wayne State University, Detroit, MI, USA; Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI, USA; Environmental Health Sciences Center, Wayne State University, Detroit, MI, USA
* To whom correspondence should be addressed. E-mail: lili{at}med.wayne.edu.
SM22
gene has widely been used to study the regulatory mechanisms of smooth muscle cell (SMC) gene expression during cardiovascular development. To determine the regulatory mechanisms for the evolutionarily conserved human SM22
(hSM22
) gene, we demonstrated that 445 bp upstream DNA sequences of hSM22
gene exhibited a high transcriptional activity in arterial SMC, not in venous nor in visceral SMCs during embryogensis. However, this promoter was gradually turned off in adulthood. Inclusion of the first intron in this promoter suppressed the promoter activity in pulmonary trunk arterial (PTA) SMCs, while the expression in other systemic vasculature remained similar to that of the hSM22-445 promoter during fetal and adult stages. To determine whether additional sequences are required for SM22
expression in all subtypes of SMCs, we examined the expression of a bacterial artificial chromosome (BAC) containing the hSM22
locus in transgenic mice. The hSM22
transgene showed similar developmental expression patterns as the endogenous mouse SM22
(mSM22
) gene, suggesting that this BAC contains essential regulatory sequences for its expression in arterial, venous and visceral tissues during development.
This article has been cited by other articles:
![]() |
L. Chang, L. Villacorta, J. Zhang, M. T. Garcia-Barrio, K. Yang, M. Hamblin, S. E. Whitesall, L. G. D'Alecy, and Y. E. Chen Vascular Smooth Muscle Cell-Selective Peroxisome Proliferator-Activated Receptor-{gamma} Deletion Leads to Hypotension Circulation, April 28, 2009; 119(16): 2161 - 2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Touw, A. M. Hoggatt, G. Simon, and B. P. Herring Hprt-targeted transgenes provide new insights into smooth muscle-restricted promoter activity Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1024 - C1032. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Qiu, R. P. Ritchie, Z. Fu, D. Cao, J. Cumming, J. M. Miano, D.-Z. Wang, H. J. Li, and L. Li Myocardin Enhances Smad3-Mediated Transforming Growth Factor-{beta}1 Signaling in a CArG Box-Independent Manner: Smad-Binding Element Is an Important cis Element for SM22{alpha} Transcription In Vivo Circ. Res., November 11, 2005; 97(10): 983 - 991. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |